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Abstract 
Gold nanoparticles have been shown to enhance radiation doses delivered to biological targets due to the 
high absorption coefficient of gold atoms, stemming from their high atomic number (Z) and physical 
density. These properties significantly increase the likelihood of photoelectric effects and Compton 
scattering interactions. Gold nanoparticles are a novel radiosensitizing agent that can potentially be used 
to increase the effectiveness of current radiation therapy techniques and improve the diagnosis and 
treatment of cancer. However, the optimum radiosensitization effect of gold nanoparticles is strongly 
dependent on photon energy, which theoretically is predicted to occur in the kilovoltage range of energy. 
In this research, synchrotron-generated monoenergetic X-rays in the 30-100 keV range were used to 
investigate the energy dependence of radiosensitization by gold nanoparticles and also to determine the 
photon energy that produces optimum effects. This investigation was conducted using cells in culture to 
measure dose enhancement. Bovine aortic endothelial cells with and without gold nanoparticles were 
irradiated with X-rays at energies of 30, 40, 50, 60, 70, 81, and 100 keV. Trypan blue exclusion assays were 
performed after irradiation to determine cell viability. Cell radiosensitivity enhancement was indicated by 
the dose enhancement factor which was found to be maximum at 40 keV with a value of 3.47. The dose 
enhancement factor obtained at other energy levels followed the same direction as the theoretical 
calculations based on the ratio of the mass energy absorption coefficients of gold and water. This 
experimental evidence shows that the radiosensitization effect of gold nanoparticles varies with photon 
energy as predicted from theoretical calculations. However, prediction based on theoretical assumptions 
is sometimes difficult due to the complexity of biological systems, so further study at the cellular level is 
required to fully characterize the effects of gold nanoparticles with ionizing radiation. 
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Abstract: Gold nanoparticles have been shown to enhance radiation doses delivered to 
biological targets due to the high absorption coefficient of gold atoms, stemming from their 
high atomic number (Z) and physical density. These properties significantly increase the likeli-
hood of photoelectric effects and Compton scattering interactions. Gold nanoparticles are a 
novel radiosensitizing agent that can potentially be used to increase the effectiveness of current 
radiation therapy techniques and improve the diagnosis and treatment of cancer. However, the 
optimum radiosensitization effect of gold nanoparticles is strongly dependent on photon energy, 
which theoretically is predicted to occur in the kilovoltage range of energy. In this research, 
synchrotron-generated monoenergetic X-rays in the 30–100 keV range were used to investigate 
the energy dependence of radiosensitization by gold nanoparticles and also to determine the 
photon energy that produces optimum effects. This investigation was conducted using cells in 
culture to measure dose enhancement. Bovine aortic endothelial cells with and without gold 
nanoparticles were irradiated with X-rays at energies of 30, 40, 50, 60, 70, 81, and 100 keV. 
Trypan blue exclusion assays were performed after irradiation to determine cell viability. Cell 
radiosensitivity enhancement was indicated by the dose enhancement factor which was found 
to be maximum at 40 keV with a value of 3.47. The dose enhancement factor obtained at other 
energy levels followed the same direction as the theoretical calculations based on the ratio of the 
mass energy absorption coefficients of gold and water. This experimental evidence shows that 
the radiosensitization effect of gold nanoparticles varies with photon energy as predicted from 
theoretical calculations. However, prediction based on theoretical assumptions is sometimes 
difficult due to the complexity of biological systems, so further study at the cellular level is 
required to fully characterize the effects of gold nanoparticles with ionizing radiation.
Keywords: gold nanoparticles, radiotherapy, monoenergetic synchrotron radiation, 
 radiosensitizers, in vitro
Introduction
Gold nanoparticles are of increasing interest in a variety of biomedical applications 
due to their unique properties. These applications include use as a radiosensitizer to 
enhance delivery of a lethal radiation dose to tumor tissue while minimizing harmful 
radiation to normal tissue. Gold nanoparticles composed of atoms with a high atomic 
number (Z) have been the target of extensive investigation for their potential appli-
cation in the treatment of cancer using ionizing radiation.1–5 Gold nanoparticles are 
well known for their high mass energy absorption coefficient due to their increased 
probability of photoelectric interaction, which occurs predominantly in the kilovolt-
age range of energy, ie, below 500 keV. This increase in probability of photoelectric 
absorption results in increased energy being deposited at the target site.1
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The technique of enhancing local tumor control by using 
high Z materials to increase the absorbed dose was initially 
investigated using iodine. Iodine compounds have been used 
as contrast agents in clinical radiology for a long time. The 
principle of contrast enhancement by such agents stems from 
the fact that iodine atoms have a higher atomic number and 
physical density than most of the atoms present in human 
body tissue. Therefore, iodine atoms will absorb X-rays more 
efficiently, leading to more variation in X-ray absorption 
across the image, leading to enhanced image contrast.
Increases in dose effects as a result of image contrast 
enhancement in radiographic imaging procedure with iodine 
contrast agent have been observed in the earlier study.6,7 The 
same properties of the iodine as a high atomic number and 
high physical density contrast agent were later utilized as a 
radiation dose enhancement tool in radiotherapy.6,7 It was 
further suggested that, by loading tumors with iodine and 
using a kilovoltage energy beam, the radiation dose could 
be concentrated preferentially in tumor tissue due to an 
increase in local photoelectric interactions. The presence of 
these iodine-based contrast agents in the tumor during the 
course of radiotherapy would lead to enhancement of the 
radiation dose at the target site due to increased absorption 
of X-rays by the iodine atoms, which in turn would result 
in generation of free radicals, thereby increasing the likeli-
hood of damage to DNA molecules in tumor cells. In other 
words, the iodine contrast agent radiosensitizes the target 
and enhances the dose delivered to the target. However, this 
was found to be most effective at the lower end of the range 
of X-ray energy used in radiotherapy.8,9 Current radiotherapy 
modalities commonly use X-ray energy in the megavoltage 
range, which is unsuitable for such an application. Investiga-
tions of radiosensitization by iodine at high photon energy 
yields show negligible dose enhancement as compared with 
kilovoltage photon energy.8,9
Radiation dose enhancement by inclusion of such heavy 
atoms in the target is anticipated to be radiation beam 
energy-dependent. This is supported by the fact that energy 
deposition by ionizing radiation is energy-dependent and 
the optimal energy value lies just above the K-edge value of 
the target atom. However, based on the dose enhancement 
factor (DEF), this might not be the case when the energy 
dependence is not linked to the K-edge value. The DEF is 
defined as the increase in dose due to the presence of heavy 
atoms in water. It is deduced from the ratio of the mass energy 
absorption coefficient of the heavy atom compared with that 
of water. Based on this definition, dependence of DEF on the 
beam energy is not directly related to the K-edge value of the 
atoms.10 Early studies of iodine atoms indicate that the DEF 
depends on the beam energy.10 However, those studies used 
radiation sources that were not monoenergetic, such as the 
X-ray tube. Using such sources of radiation, it is not possible 
to quantify the beam energy dependence of DEF values.
Studies using iodine with a monoenergetic synchrotron 
beam have demonstrated that cell radiosensitivity enhance-
ment depends on the photon beam energy as predicted by 
theoretical calculation, with an experimental maximum at 
50 keV and a minimum just below the iodine K-absorption 
edge.10 Studies of polymer gel doped with iodine showed 
similar variation in dose enhancement when compared with 
the theoretical calculations and the results of an in vitro 
study.11 This phantom study using normoxic polyacrylamide 
gel also found that the DEF peaks at 50 keV.11 These pre-
clinical studies led to the first human clinical trial of iodine 
together with monochromatic synchrotron energy in the 
treatment of cancer at the European Synchrotron  Radiation 
Facility.12 The first clinical trial using iodine as radiosen-
sitizer fostered the innovation of possible potential of the 
nanoparticle based radiosensitizer for radiation therapy.
A number of recent studies have assessed the effects of 
radiosensitization and dose enhancement using gold nano-
particles.13,14 The effects of gold nanoparticles on distribution 
of the radiation dose have been calculated using Monte Carlo 
simulation with various models. Simulated scenarios are used 
to generate interaction of individual photons and electrons 
with gold nanoparticles and predict the amount of energy 
deposited in the surrounding target.15 Many such theoreti-
cal calculation studies have demonstrated the potential of 
kilovoltage irradiation as a better energy choice compared to 
higher photon energies.13–15 The results produced by compu-
tational methods vary according to the model used, and need 
to be clarified by further experimental studies.
Experimental validation of the radiosensitizing effects of 
gold nanoparticles in vitro and in vivo provides evidence in 
support of theoretical predictions. These simulation models 
predict dose enhancement by inclusion of gold atoms as 
nanoparticles into the target but they do not give details on the 
physics and biology involved in this irradiation technique.16 
It should be noted here that these simulation models consider 
nanoparticles simply as atoms and no consideration is given 
to the characteristics of the nanoparticles as a unit. In contrast 
with iodine atoms, nanoparticles may have different mecha-
nisms of radiosensitization due to their small size (eg, a larger 
surface to volume ratio), which can alter and modify the bio-
logical system. Unlike iodine, gold nanoparticles can penetrate 
into cells easily, and the  secondary radiation produced by 
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their interaction with ionizing radiation could further damage 
DNA, leading to cell death.1,2 Hainfeld et al pioneered the use 
of gold nanoparticles as a radiosensitizer in animal models 
and found significant tumor regression leading to prolonged 
survival.1,2 Studies using cell survival as an outcome measure 
have been extensively reported following the early animal 
studies giving variation of results due to different parameters 
used such as cell lines, radiation energy, and nanoparticle 
characteristics.3–5,17
Butterworth et al recently reviewed the physical and 
biological mechanisms underlying gold nanoparticle 
radiosensitization and suggested that the variable results of 
the studies are attributable to the different gold nanoparticle 
concentrations and photon energies used.16 It is probable 
that intrinsic cell biological responses are also involved in 
radiosensitization, over and above the total physical radiation 
dose delivered. Lechtman et al performed theoretical studies 
to investigate the implications of photon energy and nanopar-
ticle size, concentration, and localization, and found that dose 
enhancement by megavoltage energy is impossible unless a 
gold nanoparticle concentration of around 1,560–1,760 mg/g 
is present in the target.15
Small gold nanoparticles conjugated to tumor-targeted 
moieties and able to be attached to a DNA structure would 
be the best option to achieve the optimal dose enhancement 
effects, together with a large increase in photoelectric absorp-
tion in the gold nanoparticles for lower energy sources.15,18 
However, McMahon et al point out that the difference 
between kV and mV results is less than 2% and biological 
factors need to be considered.19 Supported by a local effect 
model, McMahon et al suggest that dose enhancement at 
higher energy levels can be achieved via production of high 
LET (linear energy transfer) secondary charged particles 
from the primary interaction of photons with nanoparticles.19 
Experimental work by the same group on the energy depen-
dence of gold nanoparticle radiosensitization yielded results 
that departed significantly from the theoretical calculations, 
suggesting that the process of radiosensitization is complex 
and depends on various factors. Recently, a stochastic model 
of radiation dose enhancement has been described, represent-
ing the interactions of incident photons with aggregates of 
nanoparticles in cells.20
In this work, we experimentally determined the optimal 
energy for dose enhancement by gold nanoparticles using a 
bovine aortic endothelial cell survival curve based on a viabil-
ity assay as the measurement end point. A monoenergetic 
synchrotron beam in the range of 30–100 keV supplied by 
the BL20XU beam-line at the Spring-8 Biomedical  Imaging 
Center, Hyogo, Japan, was used to determine the energy 
dependence of the radiosensitization effects introduced by 
inclusion of gold nanoparticles.
Materials and methods
gold nanoparticles
The gold nanoparticles (1.9 nm diameter) used were from 
Nanoprobes Inc., (AuroVist® gold nanoparticle X-ray con-
trast agent; Yaphank, NY, USA) and were prepared according 
to the product specification instructions. They were dissolved 
in phosphate-buffered saline and the solution was then filtered 
using the centrifugal tube filter provided. Next, the gold 
nanoparticle solution was spun in a centrifuge at 10,000× g 
for 5 minutes. The solution was then diluted with complete 
cell culture medium to the final concentration.
cell culture
Bovine aortic endothelial cells were purchased from Cell 
Applications Inc., (San Diego, CA, USA) and grown in a 75 
mL flask (Iwaki and Co., Ltd., Tokyo, Japan) at 37°C and 
in a 5% CO
2
 humidified atmosphere until confluence. The 
cells were cultured in Dulbecco’s Modified Eagle’s Medium 
with GlutaMax™-I, 10% fetal bovine serum, 100 U/mL 
penicillin, and 100 µg/mL streptomycin (all from Gibco, 
Ghent, Belgium).
cell irradiation and viability
Bovine aortic endothelial cells were trypsinized and experi-
ments were conducted with the cell suspension in 1.5 mL 
sterile Eppendorf tubes with and without gold nanoparticles. 
The gold nanoparticles were then added to the cell suspen-
sion giving a final concentration of 1 mmol/L or 0.197 mg/
mL. A suspension containing approximately 50,000 cells was 
irradiated in the vertical position as shown in Figure 1. Cell 
viability assays were done using the Trypan blue exclusion 
method immediately after irradiation.
Dosimetry
The BL20XU beam-line at the Spring-8 Biomedical 
Imaging Center consists of a monoenergetic X-ray beam 
with a constant exit double-crystal monochromator  system. 
A configuration of Si (511) Si (111) was used to test 
energy levels of 30, 40, 50, 60, 70, 81, and 100 keV. The 
prospective dosimetry was performed using a calibrated 
PTW 30009 pencil-type ionization chamber and electro-
meter (PTW, Freiburg, Germany). Dose rates calculated in 
water were kept constant across the energy range (15 cGys 
per second on average). Beam sizes were measured on 
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GAFchromic® XRCT2 films (Ashland Specialty Ingre-
dients, Parlin, NJ, USA) and were approximately 0.25 
(height) ×0.5 (width) cm2. EBT2 type GAFchromic films 
were placed on the  Eppendorf tubes to verify that no geo-
metric miss occurred during irradiation. To account for 
potential fluctuations in beam intensity during irradiation of 
the samples, the doses actually delivered were recalculated 
a posteriori by measurement with the ionization chamber 
placed behind the samples.
statistical analysis
The data are expressed as the mean ± standard deviation of 
three samples. The unpaired Student’s t-test (Welch corrected) 
was used to determine the significance of differences between 
the control and experimental groups. The statistical analysis 
was performed using GraphPad InStat version 3 for Windows 
(GraphPad Software, San Diego, CA, USA).
Results
Theoretical model-based calculations of DEF values for 
atomic gold as a function of photon energy and mass 
proportion of gold in the mixture are shown in Figure 2. 
This DEF calculation is specifically based on an equation 
for a monoenergetic beam using the ratio of mass energy 
absorption coefficients obtained from the National Institute 
of Standard and Technology database.18 In this study, DEF 
 values were calculated for different photon energies and 
various proportions of gold nanoparticles following the 
same model used by Corde et al for calculation of the dose 
enhancement produced by iodine.10
Our calculations indicate a clear dependence of DEF on 
photon energy and the relative quantity of gold nanoparticles 
(Figure 2). The highest DEF value of 160 was obtained 
with 100% gold mixtures at a photon energy of 40 keV. 
This optimal energy value is well below the gold K-edge 
energy, which is 80.7 keV. In Figure 2, the DEF increases 
with increasing energy until it reaches a maximum at 40 keV 
and gradually decreases until it reaches the gold K-edge 
energy level of 80.7 keV, indicating a sharp increase in 
dose enhancement. DEF values beyond the K-edge value 
gradually decrease until almost no enhancement is present 
at energies above 1 MeV. The bell-shaped graph in Figure 2 
shows the variation of DEF with photon energy, and clearly 
indicates that there is an optimal energy where maximum 
dose enhancement by gold nanoparticles can be achieved. 
Based on this model, which calculates the mass-energy 
absorption coefficent ratio, the optimal energy for dose 
enhancement is not necessarily the K-edge value for the high 
Z atomic dose enhancer, because the optimum was found 
to be clearly inferior to the K-edge energy for gold. This 
finding is also concordant with the calculations documented 
by Corde et al for iodine atoms. The model-based predic-
tions demonstrate that maximum dose enhancement occurs 
at around 40–50 keV, and this has also been demonstrated 
experimentally.10 To investigate the energy dependence of 
0 m
Synchrotron radiation
Ionization chamber Vacuum path CCD camera
Holder
Cell sample
in tube
Radiochromic
film
Monochromatic
X-ray beam
SlitRectangular
aperture
Monochromator
46 m 50 m 80 m 240 m 245 m
Figure 1 Schematic diagram of irradiation by the BL20XU beam-line at Spring-8 Biomedical Imaging Center, Hyōgo Prefecture, Japan. Note that the figure is not drawn to scale.
Abbreviation: ccD, charge coupled device.
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Figure 2 DeF calculated for different percentages of the gold mixture in water at 
different incident photon energies. The figure shows the dependency of DeF on 
photon energy and gold concentration (from 1% to 100% mass fraction of gold in 
water). The highest DeF yield is at 40 keV. 
Abbreviation: DeF, dose enhancement factor.
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gold nanoparticle dose enhancement, monoenergetic photon 
beams were used to irradiate bovine aortic endothelial cells 
with and without gold nanoparticles in the culture medium. 
In this experiment, the effects of subcellular localization of 
gold nanoparticles were not taken into account.
Figure 3 shows the cell survival curves, all of which 
indicate a dose modification effect or radiosensitization by 
gold nanoparticles at all energy levels tested between 30 and 
100 keV and suggest that the amplitude of this phenomenon is 
energy-dependent. Empirically, the dose enhancement effect 
of 1 mM gold nanoparticles in bovine aortic endothelial cells 
is measured at each energy level by estimating the fraction 
of cells surviving after irradiation with and without gold 
nanoparticles. The experimental DEF is derived from the 
ratio of the doses necessary to decrease cell survival to 90% 
with and without gold nanoparticles and then comparing these 
0.6
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Figure 3 Survival curves for cells irradiated with and without gold nanoparticles were fitted to a linear-quadratic model at different energy levels. 
Abbreviation: auNPs, gold nanoparticles.
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with the corresponding calculated values. The cell survival 
curves were fitted according to the linear-quadratic model and 
the radiobiological parameters alpha and beta were deduced 
based on this model. The results obtained for DEF and the 
alpha and beta values are presented in Table 1.
As predicted, the DEF deduced from cell survival curves 
was found to be highest at about 40 keV, with a value of 3.47, 
followed by 50 keV and 60 keV with values of 2.77 and 3.06, 
respectively. These DEF values indicate a more than three-fold 
enhancement by gold nanoparticles in this range of energies. 
Less dose enhancement was observed for the extreme energies 
used in this experiment, despite the fact that a relatively slight 
increase in dose enhancement exists at gold K-edge energy. 
At 30 keV, a DEF of 1.74 was observed and at 70, 81, and 
100 keV, the observed DEF values were 1.3, 2.58, and 1.35, 
respectively. The experimental DEF values obtained at differ-
ent energies were compared with those based on theoretical 
calculations, as shown in Figure 4. DEF was calculated at 
the same mass concentration as that used in the experimental 
work (0.197 mg/mL). Comparison between the measured and 
calculated DEF values shows variation of change is similar in 
pattern where the DEF peaks at 40 keV. However, when the 
experimental and calculated DEF values are compared for 
each energy level, the experimental DEF was much higher 
than the calculated DEF for all radiation energy levels. The 
differences between the experimental and calculated DEF 
values are the result of many factors, including experimental 
geometry, cell radiosensitivity, and amount of radiation dose 
being absorbed that results in cell death.10 The DEF measured 
at different survival rates can also give different experimental 
results.10 Therefore, the parameters chosen for analysis are 
important when evaluating dose enhancement effects.
Discussion
Analysis of the radiobiological parameters, alpha and beta, 
computed from a linear-quadratic model, indicates no clear 
effect of gold nanoparticles on the beta value, but the alpha 
value follows almost the same trend as the DEF. Figure 5 
shows the variation in alpha values for DEF, which have a 
maximum value at around 40–50 keV, where the DEF is also 
optimum. From this analysis of radiobiological parameters, 
the low energy range could be the optimal energy level at 
which to achieve the best radiosensitization by gold nano-
particles, as indicated by the theoretical calculations. This 
suggests that the alpha value could be used as an indicator, 
resulting in enhancement of cell death. The alpha value rep-
resents the double-strand break given that alpha is the prob-
ability of an interaction between two chromosome breaks as a 
consequence of a single electron set in motion by absorption 
of X-rays. However, it should be noted that not all energy 
deposited will contribute to DNA damage through either 
single-strand breaks or double-strand breaks. The radiation 
dose will probably be absorbed into other cells and organelles, 
such as the cytoskeleton, mitochondria, lysosomes, and the 
plasma membrane, and will also affect cell interaction and 
signaling. Alterations in the cytoplasmic organelles and cell 
function caused by ionizing radiation will eventually induce 
cell death via apoptosis and necrosis.21 A study by McMahon 
et al of dose enhancement by gold nanoparticles based on 
analysis of single-strand breaks in plasmid DNA did not show 
any agreement with their theoretical data. This indicates that 
the mechanism of cell death as a result of radiosensitization 
with gold nanoparticles is a complex biological process that 
cannot be measured by a single parameter. McMahon et al 
also suggest that there is reduced radiosensitization in the 
megavoltage range of energy compared with the kilovolt-
age range of energy, but the reduction is not as great as that 
predicted theoretically.19 Variation in biological processes 
may contribute to the level of radiosensitization in the mega-
voltage range of energy, as indicated in the literature.4,17 The 
data indicate significant changes in the alpha value, while 
 minimal variations are observed in the beta parameter. Similar 
results were obtained by Lechtman et al using Monte Carlo 
simulations.22 Further measurements focusing on this variation 
between two radiobiological parameters are currently being 
undertaken by our group.
Lechtman et al found that megavoltage energy could 
not achieve significant radiosensitization unless a higher 
Table 1 Radiobiological parameters based on a linear-quadratic 
model extrapolated from cell survival curves for each energy level 
with and without gold nanoparticles
Energy 
(keV)
AuNPs 
(mmol/L)
α (Gy-1)  
(SE)
β (Gy-2)  
(SE)
DEF (at 90% 
survival)
30 0 0.038 (0.006) -0.002 (0.001)
1 0.060 (0.006) -0.003 (0.001) 1.74
40 0 0.013 (0.007)  0.001 (0.0003)
1 0.070 (0.012) -0.001 (0.001) 3.47
50 0 0.034 (0.003) -0.001 (0.0004)
1 0.088 (0.011) -0.006 (0.001) 2.77
60 0 0.003 (0.004) 0.004 (0.001)
1 0.069 (0.008) -0.001 (0.001) 3.06
70 0 0.025 (0.004) 0.001 (0.001)
1 0.026 (0.004) 0.003 (0.001) 1.3
81 0 0.022 (0.005) -0.0001 (0.001)
1 0.065 (0.011) -0.004 (0.002) 2.58
100 0 0.016 (0.004) 0.002 (0.001)
1 0.031 (0.012) 0.001 (0.002) 1.35
Abbreviations: auNPs, gold nanoparticles; DeF, dose enhancement factor; se, 
standard error.
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 concentration of gold nanoparticles was used.15 Calculation 
of the proportion of energy transferred to escaping secondary 
charged particles or internally absorbed in the nanoparticles sug-
gests that use of photon energy below the K-edge takes advan-
tage of an extremely localized Auger cascade.  Alternatively, 
implementation of high energy (above the K-edge) photons 
requires a high concentration of gold nanoparticles in the 
tumor region to acquire enough radiosensitization from the 
energy deposited by photoelectrons.15 The localization of gold 
nanoparticles may not be an issue where photoelectric absorp-
tion becomes dominant. However, an increase in biologically 
lethal effects may be achieved if the gold nanoparticles can 
be internally targeted, especially to DNA.10 However, as previ-
ously noted, cell death could be induced by damage to other 
cell structures and suborganelles via a different molecular 
mechanism, especially in the presence of gold nanoparticles.21 
Many studies have been reported that show many folds of 
radiosensitization being observed for kilovoltage energies 
which support this theory.1–3,5
The current literature reports conflicting results, and 
each study makes its own assumptions regarding the process 
of radiosensitization by gold nanoparticles in biological 
materials. Depending on the measurement end point, theo-
retical model, and analytical parameters used, the results can 
differ significantly. The clonogenic assay has been the gold 
standard for cell survival measurements and has been used in 
many radiobiological studies involving gold nanoparticles.4,5 
Other methods have also been used to examine in detail the 
in vitro effects of gold nanoparticles in cells. For example, 
McMahon et al investigated the optimal energy for gold 
nanoparticles by using plasmid DNA and gamma H2AX 
foci to observe the DNA damage.4,19,23 It is very important 
to understand every part of the cellular effects and interac-
tion with gold nanoparticles; however, the quantifying dose 
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enhancement or radiosensitizing effect essentially arises from 
the total damage effects of the biological system. Therefore, 
more multiparametric approaches to measurement that 
take into account all the biological damage contributing to 
the radiosensitization effects must be carried out.
In optimizing the methods used for measuring radiosensi-
tization in biological materials, polymer gel dosimetry could 
be a useful method to physically validate the dose enhance-
ment effects produced by gold nanoparticles. A recent study 
of polymer gel dosimetry (normoxic polyacrylamide gel 
and radiochromic gel), show more dose enhancement in the 
kilovoltage range of energy than in the megavoltage range of 
energy.24,25 Comparison of the results for both types of gel is 
in close agreement, where the variation of DEF obtained for 
6 mV is 1.14 (polymer gel) and 1.11 (presage gel) while the 
DEF obtained at around 80 kV energy is 1.76 (polymer gel) 
and 1.77 (presage gel).24,25 In contrast with the unpredictable 
behavior and variation of biological materials, polymer gel 
dosimetry provides a more controlled environment for the 
measurement of the physical dose enhancement effects of 
gold nanoparticles.
Conclusion
This study demonstrates the effects of radiation energy on 
the radiosensitization effects of gold nanoparticles on cells in 
culture. The results obtained clearly demonstrate that the cel-
lular radiosensitization effects in the presence of gold nano-
particles are energy-dependent, and the  experimental results 
are in close agreement with the theoretical  calculations. The 
optimal energy was found to be around 40 keV, as predicted 
from the calculated ratio of the mass energy absorption 
coefficients for water and gold. The increase in deposited 
energy induced by gold nanoparticles may be closely related 
to cellular radiosensitization, but the relationship between 
them requires further investigation and consideration of 
multiple factors.
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